SIC
SBRA icon

Samalin Investment Counsel’s Sabra Healthcare REIT SBRA Stock Holding History

Samalin Investment Counsel’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
24,363
+842
+4% +$16.7K 0.15% 166
2026
Q1 		$452K Buy
23,521
+413
+2% +$8.13K 0.16% 176
2025
Q4 		$438K Sell
23,108
-340
-1% -$6.3K 0.16% 186
2025
Q3 		$437K Sell
23,448
-1,506
-6% -$28.1K 0.15% 191
2025
Q2 		$460K Buy
24,954
+4,029
+19% +$71.5K 0.18% 184
2025
Q1 		$366K Buy
20,925
+6,668
+47% +$112K 0.15% 205
2024
Q4 		$247K Buy
14,257
+1,437
+11% +$26.2K 0.11% 244
2024
Q3 		$239K Buy
12,820
+202
+2% +$3.41K 0.1% 247
2024
Q2 		$194K Sell
12,618
-1,171
-8% -$16.7K 0.09% 261
2024
Q1 		$204K Sell
13,789
-239
-2% -$3.31K 0.1% 259
2023
Q4 		$200K Sell
14,028
-1,652
-11% -$23.5K 0.1% 255
2023
Q3 		$219K Buy
15,680
+322
+2% +$4.12K 0.13% 229
2023
Q2 		$181K Sell
15,358
-2,457
-14% -$28K 0.1% 252
2023
Q1 		$205K Buy
17,815
+150
+0.8% +$1.86K 0.12% 221
2022
Q4 		$220K Buy
17,665
+332
+2% +$4.23K 0.14% 210
2022
Q3 		$227K Buy
17,333
+268
+2% +$3.96K 0.17% 180
2022
Q2 		$238K Sell
17,065
-730
-4% -$9.76K 0.17% 184
2022
Q1 		$265K Buy
17,795
+3,970
+29% +$54.3K 0.16% 189
2021
Q4 		$187K Sell
13,825
-4,801
-26% -$67.9K 0.11% 229
2021
Q3 		$274K Buy
18,626
+2,343
+14% +$39.6K 0.18% 179
2021
Q2 		$296K Sell
16,283
-2,519
-13% -$44.8K 0.19% 175
2021
Q1 		$326K Sell
18,802
-116
-0.6% -$2.04K 0.22% 157
2020
Q4 		$329K Sell
18,918
-16,852
-47% -$269K 0.25% 145
2020
Q3 		$493K Buy
35,770
+17,398
+95% +$256K 0.44% 69
2020
Q2 		$265K Sell
18,372
-694
-4% -$9.12K 0.28% 120
2020
Q1 		$208K Buy
19,066
+282
+2% +$5.2K 0.28% 110
2019
Q4 		$400K Buy
+18,784
New +$421K 0.34% 79

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Samalin Investment Counsel's SBRA Position: Q2 2026 in Review

Samalin Investment Counsel increased its Sabra Healthcare REIT (SBRA) stake by 3.6% in Q2 2026, buying an estimated $16.7K and bringing the position to 24,363 shares worth $475K. The position accounts for 0.15% of the portfolio, ranked #166.

Samalin Investment Counsel first reported a position in SBRA in Q4 2019 and has held it in 27 quarters since. The position peaked at $493K in Q3 2020. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Samalin Investment Counsel held 24,363 shares of Sabra Healthcare REIT worth $475K as of Q2 2026.
  • Samalin Investment Counsel bought 842 Sabra Healthcare REIT shares in Q2 2026, an estimated $16.7K.
  • Sabra Healthcare REIT made up 0.15% of Samalin Investment Counsel's portfolio in Q2 2026, its #166 holding.
  • Samalin Investment Counsel first reported a position in Sabra Healthcare REIT in Q4 2019 and has held it in 27 quarters since.
  • Samalin Investment Counsel's Sabra Healthcare REIT position peaked at $493K in Q3 2020.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.